Correction to: Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
- PMID: 33860435
- DOI: 10.1007/s10555-021-09966-2
Correction to: Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
Erratum for
-
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?Cancer Metastasis Rev. 2021 Mar;40(1):3-5. doi: 10.1007/s10555-021-09955-5. Cancer Metastasis Rev. 2021. PMID: 33454844 Free PMC article. No abstract available.
Similar articles
-
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?Cancer Metastasis Rev. 2021 Mar;40(1):3-5. doi: 10.1007/s10555-021-09955-5. Cancer Metastasis Rev. 2021. PMID: 33454844 Free PMC article. No abstract available.
-
Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.Front Oncol. 2022 Jun 13;12:922945. doi: 10.3389/fonc.2022.922945. eCollection 2022. Front Oncol. 2022. PMID: 35769713 Free PMC article. Review.
-
Disrupted Blood-Brain Barrier and Mitochondrial Impairment by Autotaxin-Lysophosphatidic Acid Axis in Postischemic Stroke.J Am Heart Assoc. 2021 Sep 21;10(18):e021511. doi: 10.1161/JAHA.121.021511. Epub 2021 Sep 13. J Am Heart Assoc. 2021. PMID: 34514847 Free PMC article.
-
A novel highly potent autotaxin/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension.PLoS One. 2014 Apr 18;9(4):e93230. doi: 10.1371/journal.pone.0093230. eCollection 2014. PLoS One. 2014. PMID: 24747415 Free PMC article.
-
The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer.Tumour Biol. 2017 Mar;39(3):1010428317694544. doi: 10.1177/1010428317694544. Tumour Biol. 2017. PMID: 28347252 Review.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources